Home > Boards > US OTC > Cannabis >

OWC Pharmaceutical Research Corp. (OWCP)

OWCP RSS Feed
Add OWCP Price Alert      Hide Sticky   Hide Intro
Moderator: Blue Skys, Hole shot King, stockfan100, Taurus69, Homebrew, PhenixBleu
Search This Board: 
Last Post: 9/25/2020 11:11:11 PM - Followers: 1107 - Board type: Free - Posts Today: 80


AUDIO - 08/31/2020 SHAREHOLDER MEETING
(Transcript to Follow)
AUDIO - 09/14/2020 SHAREHOLDER MEETING

"Transforming cannabis into scientifically proven and clinically approved medical solutions"

U.S. Patent 10,603,301 Issued March 31, 2020 - Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders



-- NATIONAL INSTITUTE OF HEALTH CLINICAL TRIALS --



OWC Pharmaceutical Research Corp. (OWCP)
A Delaware Corporation since March 6, 2008

11 Anne Frank Street
Petah Tikva, Israel 4931113


IR@OWCPHARMA.COM

 


         
EDGAR FACEBOOK OTC PROFILE TWITTER WEBSITE
 


OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd. ("OWC"), of conducting
medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis
specifically designed for the treatment of several illnesses/medical conditions including Multiple Myeloma, Psoriasis, Fibromyalgia, Migraine, and PTSD.

 Our business plan includes entering into collaborative ventures with major medical centers and highly regarded researchers in Israel and potentially
other countries with the goal of developing novel therapeutic methods for the treatment of serious medical conditions with cannabis-based therapies and are
conducting pre-clinical investigations and randomized, placebo-controlled trials of cannabis-based compounds and develop unique, condition-specific products.

 

AUTHORIZED  500,000,000 OUTSTANDING  497,498,338 FLOAT  206,509,849
TA Verified 07/01/20 TA Verified 07/01/20 02/09/20


-- Leadership Team --


Ziv Turner
Chairman and CEO
Ziv's Private Cannabis Businesses
Cannible
The PeliCann


Shmuel De-Saban
CFO and Board Member


Dr. Med Yehuda Baruch
Chief Medical & Regulatory Officer
ADVISORY BOARD

Amir Ohad - Financial Advisor
Zvi Riterband - Financial Advisor
Dr. Gila Shimoni - Patent Advisor

 

-- Research --
 


Therapies for Skin Diseases
 
Delivery System for Pain Management Multiple Myeloma



--Intellectual Property--

ALL PUBLISHED PATENT APPLICATIONS NAME ONE WORLD CANNABIS AS THE ASSIGNEE (OWNER)

OWCP's Intellectual Property Portfolio comprises 9 patent families and includes 31 filings in selected domains at various stages from PCT filings, National Phase filings
and Continuations in Part (CIP).  The National Phase is the second of the two main phases of the Patent Cooperation Treaty (PCT) procedure. It follows the international phase and consists
of the processing of the international application before each office of or acting for a contracting state of the PCT that has been designated in the international application.

The table below will be updated when the  unknown patent families and additional patent applications are identified.

RICHTER & SHIMONI
OWC's main Patent Agency located in Israel, Germany and Switzerland
Richter engages patent lawyers in other domains for filing purposes
Dr. Gila Shimoni is primary author/editor of patent application content


BROWDY & NEIMARK'S WEBSITE (USPTO)
Browdy is OWC's U.S. Intellectual Property Law Firm

DENNEMEYER & CO. WEBSITE (AUSPAT)

Chronic Pain - Emulsions
ACTIONS TAKEN WITHIN PAST 30 DAYS


     AUSPAT (Australia) (AU)     Canadian Intellectual Property Office (CA)    Czech IPO (CZ)    European Patent Register (EPR)    Israel Patent Office (IL)     US Patent & Trademark Office (USPTO)       WIPO Patentscope (WIPO)
To search for USPTO Patent records, enter the Application Number in the search field.  View documents under Image File Wrapper tab.  To download, check the box in far right column, then click on PDF button above it.

Count Patent Family Invention Name Application No. Filing
Date
Filing
Domain
Application
Published
Last Action Last Action Date Patent No. Patent Granted
1   Multiple Myeloma 1 Novel Cannabinoid Combination Therapies for Multiple Myeloma (MM) PCT/IL2016/050608 06.09.2016 WIPO 12.15.2016        
2   " 2016276563 06.09.2016 AU 12.15.2016 Renewal Fee Paid 06.09.2020    
3   " 2988869 06.09.2016 CA 12.15.2016 Renewal
Fee Paid
06.09.2020    
4   " 15580718 06.09.2016 USPTO 05.07.2018 Non-Final
Rejection
05.12.2020    
5   " 16807035 06.09.2016 EPR 04.18.2018 Reply to Examination Report 08.12.2020    
6   " 256209 06.11.2015 IS 02.28.2018 Incoming Correspondence 04.28.2020    
7   Multiple Myeloma 2 Synergistic Use of Cannabis for Treating Multiple Myeloma (MM) PCT/IL2015/051138 11.24.2015 WIPO 02.06.2016        
8   " 15/863,361 11.24.2015 EPR 04.10.2017 Amended Claims 06.13.2020    
9   " 2015351937 11.24.2015 AU 02.06.2016 Examination
Report #1
03.06.2020    
10   " 2968929 11.24.2015 CA 02.06.2016 Renewal
Fee Paid
11.12.2019    
11   " 252504 11.26.2014 IS 07.31.2017 Response to Notice of Objection 03.23.2020    
12   " 15531047 11.24.2015 USPTO 10.25.2018 Abandonment 10.10.2019    
13   Fibromyalgia Use of Cannabis to Treat Fibromyalgia, Methods and Compositions Thereof PCT/IL2016/050498 05.11.2016 WIPO 11.17.2016        
14   " 2016261707 05.11.2016 AU 11.17.2016 Examination Report #1 06.30.2020    
15   " 2985969 05.11.2016 CA 11.17.2016 Renewal
Fee Paid
05.07.2020    
16   " 16792308.5 05.11.2016 EPR 03.21.2018 Renewal
Fee Paid
05.09.2020    
17   " 15573687 05.11.2016 USPTO 05.03.2018 Abandonment 02.20.2020    
18   " 255615 05.13.2015 IS 01.31.2018 Notice of Objection 02.17.2020    
19   Pharmaceutical Emulsions Preparations of Cannabis Emulsions and Methods Thereof   PCT/IL2016/050289 03.17.2016 WIPO 09.22.2016        
20   " 16764344 03.17.2016 EPR 01.24.2018 Renewal
Fee Paid
03.11.2020    
21   " 2982250 03.17.2016 CA 09.22.2016 Renewal
Fee Paid
03.09.2020    
22   " 2016231788 03.17.2016 AU 09.22.2016 Exam Report #1 06.16.2020    
23   " 15708187 09.19.2017 USPTO 02.15.2018 Amendments/RFR Forwarded to Examiner 07.10.2020    
24   " 254598 03.19.2015 IS 11.20.2017 Notice of Objection 01.19.2020    
25   Migraine Use of Cannabis to Treat Migraine   PCT/IL2015/051184 07.12.2015 WIPO 06.16.2016        
26   " 15533684 06.07.2017 USPTO 10.11.2018 Abandonment 07.11.2019    
27   " EP15863361 11.24.2015 EPR 04.10.2017 Deemed Withdrawn 10.26.2018    
28   Sexual Function Novel Condom Comprising Cannabis Derived Compositions for Enhancement of Sexual Pleasure and Decrease of Erectile Dysfunction Symptoms PCT/IL2015/051220 16.12.2015 WIPO 06.23.2016        
29   " 15536738 16.12.2015 USPTO 12.28.2017 Final Rejection 07.22.2020    
30   " EP15869472 16.12.2015 EPR 06.23.2016 Deemed
Withdrawn
07.27.2018    
31   " 2971144 12.17.2014 CA 06.23.2016 Renewal
Fee Paid
12.02.2019    
32 Skin Disorders Use of Cannabis to Treat Psoriasis* PCT/IL2015/051234 12.21.2015 WIPO 06.30.2016 Deemed
Withdrawn
06.22.2018    
33 Skin Disorders Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders 2015101908 12.21.2015 AU 06.30.2016 GRANTED   2015101908 11.08.2017
34   " 253066 12.21.2014 IS 08.31.2017 Notice of Objection 04.03.2020    
35   " 15629230 06.21.2017 USPTO 02.15.2018 GRANTED   10,603,301 03.31.2020
36   " 2971197 06.20.2017 CA 12.20.2018 Renewal
Fee Paid
06.19.2020    
37   " 17178303 06.28.2017 EPR 12.26.2018 Renewal Fee Paid 06.23.2020    
38 Skin Disorders Hemp extracts and topical preparations for use in skin disorders 2017-33913 7.14.2017 CZ 10.31.2018 GRANTED     01.01.2019

*The Psoriasis agreement with Sheba Academic Medical Center provides that all intellectual property that is conceived during the course of the research is to be jointly owned by Sheba and One World Cannabis.

 


RELATED ARTICLES / OPINIONS

OWCP NEWS 2019 - 2020

Marijuana Legalization: Israeli Pharmacies To Start Selling Medical Cannabis - IB Times

Canadian Pharmacies to Start Selling Medical Cannabis

Marijuana Set To Become Billion Dollar Industry in Canada

German Pharmacies To Start Selling Medical Cannabis

Australia Cannabis to be Legalized 


Israel to allow Medical Marijuana Exports
 

01-30-2019 - OWC Pharmaceutical Research Corp. Reports Positive Safety Data From Phase 1 (Safety) Clinical Trial
for Medical Grade Cannabis Ointment for Treatment of Skin Diseases


02-11-2019 Chairman's Letter to Shareholders


03-27-19 - OWC Pharmaceutical Research Corp. to Collaborate with Sourasky Medical Center
in Tel Aviv for a Safety Study on Its Cannabis-Based Tablets


08-05-2019 - OWC Pharmaceutical Research Received a Permit for a Cannabis Based Ointment Efficacy Trial

10-7-2019 - OWC Pharmaceutical Research Corp. to Report Top Line Results (TLR)
for a Safety Study on Its Cannabis-based Tablets


12-16-2019 - OWC Israel's Patent for Cannabis Based Extracts and Topical Formulations
for Use in Skin Disorders, Is Allowed for Issuance as a Patent in the USA

 

-- ACTIVE LITIGATION --

OWC Pharmaceutical Research Corp is the Plaintiff in both cases filed in Supreme Court of New York County.
Link to Filings

CASE CAPTION CASE NUMBER CASE TYPE
   OWC Pharmaceutical Research Corp. v. Sichenzia Ross Ference Kesner LLP
   f/k/a Sichenzia Ross Friedman Ference LLP et al
152373/2017   Torts - Other Professional Malpractice
     
 
OWCP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OWCP News: Current Report Filing (8-k) 02:30 PM
OWCP News: Additional Proxy Soliciting Materials (definitive) (defa14a) 09/04/2020 12:37:48 PM
OWCP News: Current Report Filing (8-k) 09/02/2020 01:58:52 PM
OWCP News: Proxy Statement (definitive) (def 14a) 08/14/2020 10:22:04 AM
OWCP News: Proxy Soliciting Materials (revised) (prer14a) 07/27/2020 04:06:16 PM
News News Alert: Current Report Filing (8-k) 09/25/2020 02:30:16 PM
PostSubject
#185776  Sticky Note U.S. Patent 10,603,301 - Cannabis-based extracts and topical PhenixBleu 03/31/20 06:31:34 AM
#179464  Sticky Note $owcp $.15 with news Taurus69 01/09/20 12:12:54 AM
#175972  Sticky Note Meet Dr. Zeevi, Our CSO , and her Accomplishments! stockfan100 01/01/20 11:17:24 AM
#131717  Sticky Note And here is the complaint: janice shell 03/07/18 03:31:58 PM
#69890  Sticky Note Board Warning - Please Read: IH Admin [Shelly] 03/10/17 08:29:29 AM
#195779   From the Delaware Securities Act. "This chapter shall I-Glow 09/25/20 11:11:11 PM
#195778   Does anyone else think these guys are just H_dog_taco 09/25/20 10:53:06 PM
#195777   well done CBT.. letitride168 09/25/20 10:04:25 PM
#195776   With regards to the voting rights of Preferred BruceLake 09/25/20 09:11:29 PM
#195775   HOW MANY VOTES ARE NEEDED FOR A QUORUM? CanItBThisEZ2Make 09/25/20 08:58:08 PM
#195774   Since you work for OWCP/Turner and you posted I-Glow 09/25/20 08:18:35 PM
#195773   Who cares about the EPO - we went I-Glow 09/25/20 08:16:27 PM
#195772   I have already posted the correct information about I-Glow 09/25/20 08:03:31 PM
#195771   I thought Browdy had been replaced since he I-Glow 09/25/20 08:00:10 PM
#195768   The examiner is a bit of a mystery. Blue Skys 09/25/20 06:40:08 PM
#195767   "Seems the vote will get done about when letitride168 09/25/20 06:06:39 PM
#195766   Meanwhile our patent examiner has had the response Blue Skys 09/25/20 05:29:51 PM
#195765   Agreed... should be a slam dunk with no question letitride168 09/25/20 05:06:06 PM
#195764   Agree! Come on folks. Let’s get the AS fat_tire 09/25/20 04:49:35 PM
#195763   Why don't you provide a real public service, BruceLake 09/25/20 04:26:32 PM
#195762   Actually in this case filing a 10-K has BruceLake 09/25/20 04:18:46 PM
#195761   "Numbers in the 8k concern option 3..." letitride168 09/25/20 03:48:07 PM
#195760   There's a NEW application on the European Register. PhenixBleu 09/25/20 03:44:26 PM
#195759   So will they use another proxy agent? RollTheBones 09/25/20 03:41:05 PM
#195758   Not sure what numbers you're working from.... MjMilo 09/25/20 03:18:00 PM
#195757   #3 Debunkinator 09/25/20 03:16:03 PM
#195756   what.... letitride168 09/25/20 03:13:44 PM
#195755   Get the damn AS voted in so we Debunkinator 09/25/20 03:11:09 PM
#195754   Have no fear! OWCP is here! lokelo113 09/25/20 02:52:34 PM
#195753   So we still in ICU. But ventilators still Johnny risk 09/25/20 02:51:40 PM
#195752   Me too. OWCP long! GP65 09/25/20 02:35:49 PM
#195751   https://www.sec.gov/Archives/edgar/data/1431934/000149315220018346/form8-k.htm Fighting for th MjMilo 09/25/20 02:35:27 PM
#195750   DITTO OW LONG Debunkinator 09/25/20 02:32:36 PM
#195749   8k out! Not enough votes, now trying GP65 09/25/20 02:32:04 PM
#195748   Excellent. I don’t have to listen to all C to the E 09/25/20 02:25:27 PM
#195747   8K should be out shortly..that means today. MjMilo 09/25/20 02:24:26 PM
#195746   Exciting times! This will all end well. $OWCP STRONG HANDS!! fat_tire 09/25/20 02:17:41 PM
#195745   IT'S SHOW TIME!!!!!! CanItBThisEZ2Make 09/25/20 01:16:45 PM
#195744   What Journal was this submitted to - as I-Glow 09/25/20 01:07:56 PM
#195743   So Turner has another excuse for delaying I-Glow 09/25/20 01:04:18 PM
#195742   From the Delaware Securities Act. "This chapter shall I-Glow 09/25/20 01:02:06 PM
#195741   Filing a 10-K has absolutely nothing to do I-Glow 09/25/20 12:55:12 PM
#195740   Preferred stock has no set prescription or formula I-Glow 09/25/20 12:51:47 PM
#195739   That isn't correct because the Preferred Shares I-Glow 09/25/20 12:46:45 PM
#195738   I don't think we'll ever know what was MjMilo 09/25/20 12:45:55 PM
#195737   Pignitz said no because it'd deplete his slush Trooth 09/25/20 12:43:38 PM
#195736   Do you have proof of this or I-Glow 09/25/20 12:29:39 PM
#195735   Dr. Baruch has prepared an extensive analysis of MjMilo 09/25/20 12:29:12 PM
#195734   Why isn't the Transfer Agent taking care of I-Glow 09/25/20 12:27:36 PM
#195733   Hey Milo.... x100xPercent 09/25/20 12:23:44 PM
#195732   NO..there are other legal legitimate ways forward.... MjMilo 09/25/20 12:15:55 PM
#195731   The only legitimate way forward is to have Smallville 09/25/20 12:02:22 PM
#195730   Recently the company checked with the securities authorities MjMilo 09/25/20 11:40:31 AM
#195729   Milo, I don't recall we asked ZT on the letitride168 09/25/20 11:15:07 AM
#195728   Just another albatross he'll have to deal with cbuontempo 09/25/20 10:40:50 AM
PostSubject
Consent Preferences